Vessella RL - Search Results

1

Prostate stem cell antigen is overexpressed in prostate cancer metastases.

Lam JS, Yamashiro J, Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW, Reiter RE. Lam JS, et al. Among authors: vessella rl. Clin Cancer Res. 2005 Apr 1;11(7):2591-6. doi: 10.1158/1078-0432.CCR-04-1842. Clin Cancer Res. 2005. PMID: 15814638

2

Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.

Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE. Tanaka H, et al. Among authors: vessella rl. Nat Med. 2010 Dec;16(12):1414-20. doi: 10.1038/nm.2236. Epub 2010 Nov 7. Nat Med. 2010. PMID: 21057494 Free PMC article.

3

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.

Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL. Whang YE, et al. Among authors: vessella rl. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5246-50. doi: 10.1073/pnas.95.9.5246. Proc Natl Acad Sci U S A. 1998. PMID: 9560261 Free PMC article.

4

Prostate cancer cell phenotypes based on AGR2 and CD10 expression.

Ho ME, Quek SI, True LD, Morrissey C, Corey E, Vessella RL, Dumpit R, Nelson PS, Maresh EL, Mah V, Alavi M, Kim SR, Bagryanova L, Horvath S, Chia D, Goodglick L, Liu AY. Ho ME, et al. Among authors: vessella rl. Mod Pathol. 2013 Jun;26(6):849-59. doi: 10.1038/modpathol.2012.238. Epub 2013 Jan 25. Mod Pathol. 2013. PMID: 23348903 Free PMC article.

5

Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells.

Zhau HE, He H, Wang CY, Zayzafoon M, Morrissey C, Vessella RL, Marshall FF, Chung LW, Wang R. Zhau HE, et al. Among authors: vessella rl. Clin Cancer Res. 2011 Apr 15;17(8):2159-69. doi: 10.1158/1078-0432.CCR-10-2523. Epub 2011 Feb 25. Clin Cancer Res. 2011. PMID: 21355075 Free PMC article.

6

Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol.

Corey E, Quinn JE, Emond MJ, Buhler KR, Brown LG, Vessella RL. Corey E, et al. Among authors: vessella rl. Clin Cancer Res. 2002 Apr;8(4):1003-7. Clin Cancer Res. 2002. PMID: 11948106

7

Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, Oswin MM, Lange PH, Vessella RL. Melchior SW, et al. Among authors: vessella rl. Clin Cancer Res. 1997 Feb;3(2):249-56. Clin Cancer Res. 1997. PMID: 9815680

8

Differential expression of osteonectin/SPARC during human prostate cancer progression.

Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL. Thomas R, et al. Among authors: vessella rl. Clin Cancer Res. 2000 Mar;6(3):1140-9. Clin Cancer Res. 2000. PMID: 10741745

9

Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.

Brown JM, Vessella RL, Kostenuik PJ, Dunstan CR, Lange PH, Corey E. Brown JM, et al. Among authors: vessella rl. Clin Cancer Res. 2001 Oct;7(10):2977-83. Clin Cancer Res. 2001. PMID: 11595685

10

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.

Corey E, Brown LG, Quinn JE, Poot M, Roudier MP, Higano CS, Vessella RL. Corey E, et al. Among authors: vessella rl. Clin Cancer Res. 2003 Jan;9(1):295-306. Clin Cancer Res. 2003. PMID: 12538482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page